Incidence and relationship of medically attended adverse events (MAAEs), adverse events of special interest (AESIs) (predefined list), and serious adverse events (SAEs);Incidence, duration, and severity of solicited local and systemic adverse events (AEs);Incidence, duration, severity, and relationship of unsolicited AEs through 28 days;MN50 GMTs to the SARS-CoV-2 B.1.351 (Beta) expressed as GMT;MN50 GMTs to the SARS-CoV-2 B.1.351 (Beta) expressed as SCRs/SRRs;MN50 GMTs to the SARS-CoV-2 B.1.617.2 (Delta)expressed as GMT;MN50 GMTs to the SARS-CoV-2 B.1.617.2 (Delta)expressed as SCRs/SRRs

Incidence and relationship of medically attended adverse events (MAAEs), adverse events of special interest (AESIs) (predefined list), and serious adverse events (SAEs);Incidence, duration, and severity of solicited local and systemic adverse events (AEs);Incidence, duration, severity, and relationship of unsolicited AEs through 28 days;MN50 GMTs to the SARS-CoV-2 B.1.351 (Beta) expressed as GMT;MN50 GMTs to the SARS-CoV-2 B.1.351 (Beta) expressed as SCRs/SRRs;MN50 GMTs to the SARS-CoV-2 B.1.617.2 (Delta)expressed as GMT;MN50 GMTs to the SARS-CoV-2 B.1.617.2 (Delta)expressed as SCRs/SRRs